+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuropathic Pain Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4848408
  • Report
  • September 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Biogen Idec Inc.
  • Depomed Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
The report on the global neuropathic pain market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global neuropathic pain market to grow with a CAGR of 6.1% over the forecast period from 2019-2025. The study on neuropathic pain market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on neuropathic pain market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global neuropathic pain market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global neuropathic pain market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The increasing occurrence of diabetes and cancer
  • The increase in the geriatric population
2) Restraints
  • Severe side effects of opioids and steroids
3) Opportunities
  • Strong healthcare infrastructure and well-established reimbursements
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global neuropathic pain market is segmented on the basis of type, indication, diagnosis, treatment, distribution channel, and end user.

The Global Neuropathic Pain Market by Type
  • Phantom Limb Pain
  • Trigeminal Neuralgia
  • Post Herpetic Neuralgia
  • Post-traumatic Neuropathy
The Global Neuropathic Pain Market by Indication
  • Spinal Stenosis
  • Diabetic Neuropathy
The Global Neuropathic Pain Market by Diagnosis
  • Imaging Physical Examination
o Electromyography
o MRI
o CT
  • Blood Tests
The Global Neuropathic Pain Market by Treatment
  • Medication Type
  • NSAIDs Type
o Naproxen
o Ibuprofen
o Others
  • Antidepressant Drugs Type
o Tricyclic Antidepressants
o Serotonin Noradrenaline
  • Multimodal Therapy
The Global Neuropathic Pain Market by Distribution Channel
  • Retail Pharmacies and Drug Stores
  • Online Pharmacies
The Global Neuropathic Pain Market by End User
  • Hospitals
  • Clinics
Company Profiles

The companies covered in the report include
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Eli Lily and Company
- GlaxoSmithKline PLC
  • Bristol-Myers Squibb and Company
  • Sanofi S.A.
  • Biogen Idec Inc.
  • Baxter Healthcare Corporation
  • Depomed Inc.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the neuropathic pain market.
2. Complete coverage of all the segments in the neuropathic pain market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global neuropathic pain market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Biogen Idec Inc.
  • Depomed Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Neuropathic Pain Market Highlights
2.2. Neuropathic Pain Market Projection
2.3. Neuropathic Pain Market Regional Highlights

3. Global Neuropathic Pain Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Indication
3.4.3. Growth Matrix Analysis by Diagnosis
3.4.4. Growth Matrix Analysis by Treatment
3.4.5. Growth Matrix Analysis by Distribution Channel
3.4.6. Growth Matrix Analysis by End User
3.4.7. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Neuropathic Pain Market

4. Neuropathic Pain Market Macro Indicator Analysis

5. Global Neuropathic Pain Market by Type
5.1. Phantom Limb Pain
5.2. Trigeminal Neuralgia
5.3. Post Herpetic Neuralgia
5.4. Post-traumatic Neuropathy

6. Global Neuropathic Pain Market by Indication
6.1. Spinal Stenosis
6.2. Diabetic Neuropathy

7. Global Neuropathic Pain Market by Diagnosis
7.1. Imaging Physical Examination
7.1.1. Electromyography
7.1.2. MRI
7.1.3. CT
7.2. Blood Tests

8. Global Neuropathic Pain Market by Treatment
8.1. Medication Type
8.2. NSAIDs Type
8.2.1. Naproxen
8.2.2. Ibuprofen
8.2.3. Others
8.3. Antidepressant Drugs Type
8.3.1. Tricyclic Antidepressants
8.3.2. Serotonin Noradrenaline
8.4. Multimodal Therapy

9. Global Neuropathic Pain Market by Distribution Channel
9.1. Retail Pharmacies And Drug Stores
9.2. Online Pharmacies

10. Global Neuropathic Pain Market by End User
10.1. Hospitals
10.2. Clinics

11. Global Neuropathic Pain Market by Region 2019-2025
11.1. North America
11.1.1. North America Neuropathic Pain Market by Type
11.1.2. North America Neuropathic Pain Market by Indication
11.1.3. North America Neuropathic Pain Market by Diagnosis
11.1.4. North America Neuropathic Pain Market by Treatment
11.1.5. North America Neuropathic Pain Market by Distribution Channel
11.1.6. North America Neuropathic Pain Market by End User
11.1.7. North America Neuropathic Pain Market by Country
11.2. Europe
11.2.1. Europe Neuropathic Pain Market by Type
11.2.2. Europe Neuropathic Pain Market by Indication
11.2.3. Europe Neuropathic Pain Market by Diagnosis
11.2.4. Europe Neuropathic Pain Market by Treatment
11.2.5. Europe Neuropathic Pain Market by Distribution Channel
11.2.6. Europe Neuropathic Pain Market by End User
11.2.7. Europe Neuropathic Pain Market by Country
11.3. Asia-Pacific
11.3.1. Asia-Pacific Neuropathic Pain Market by Type
11.3.2. Asia-Pacific Neuropathic Pain Market by Indication
11.3.3. Asia-Pacific Neuropathic Pain Market by Diagnosis
11.3.4. Asia-Pacific Neuropathic Pain Market by Treatment
11.3.5. Asia-Pacific Neuropathic Pain Market by Distribution Channel
11.3.6. Asia-Pacific Neuropathic Pain Market by End User
11.3.7. Asia-Pacific Neuropathic Pain Market by Country
11.4. RoW
11.4.1. RoW Neuropathic Pain Market by Type
11.4.2. RoW Neuropathic Pain Market by Indication
11.4.3. RoW Neuropathic Pain Market by Diagnosis
11.4.4. RoW Neuropathic Pain Market by Treatment
11.4.5. RoW Neuropathic Pain Market by Distribution Channel
11.4.6. RoW Neuropathic Pain Market by End User
11.4.7. RoW Neuropathic Pain Market by Sub-region

12. Company Profiles and Competitive Landscape
12.1. Competitive Landscape in the Global Neuropathic Pain Market
12.2. Companies Profiled
12.2.1. Johnson & Johnson Services Inc.
12.2.2. Pfizer Inc.
12.2.3. Eli Lily and Company
12.2.4. GlaxoSmithKline PLC
12.2.5. Bristol-Myers Squibb and Company
12.2.6. Sanofi S.A.
12.2.7. Biogen Idec Inc.
12.2.8. Baxter Healthcare Corporation
12.2.9. Depomed Inc.

13. Appendix
13.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Johnson & Johnson Services Inc.
  • Pfizer Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC
  • Bristol-Myers Squibb and Company
  • Sanofi S.A.
  • Biogen Idec Inc.
  • Baxter Healthcare Corporation
  • Depomed Inc.
Note: Product cover images may vary from those shown
Adroll
adroll